Latest Schedule 13G passive stakes

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have updated their beneficial ownership filing for Karyopharm Therapeutics Inc., reporting a 6.3% stake.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have updated their beneficial ownership filing for Karyopharm Therapeutics Inc., reporting a 6.3% stake.

Harlan B. Korenvaes and Spruce Trust have jointly filed a Schedule 13G, reporting beneficial ownership of 5.9% of MSC Industrial Direct Co Inc's Class A Common Stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.8% of Oceanhawk Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.8% of Oceanhawk Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

Goldman Sachs Asset Management, L.P. has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 4.7% in Kinetik Holdings Inc. Class A common stock as of June 30, 2026.

Mark D. Becker has filed a Schedule 13G, disclosing beneficial ownership of 1,437,573 shares, representing 3.0% of Hallador Energy Co.'s common stock.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 443,867 Class A ordinary shares of Lake Superior Acquisition Co.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 443,867 Class A ordinary shares of Lake Superior Acquisition Co.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 676,022 shares, representing 4.8% of Graf Global Corp.'s Class A ordinary shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 676,022 shares, representing 4.8% of Graf Global Corp.'s Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.8% of GenEdx Holdings Corp.'s Class A common stock as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.8% of GenEdx Holdings Corp.'s Class A common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting a change in beneficial ownership of D. Boral Arc Acquisition I Corp. Class A ordinary shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting a change in beneficial ownership of D. Boral Arc Acquisition I Corp. Class A ordinary shares.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Agilon Health, Inc. common stock.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Agilon Health, Inc. common stock.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting a 4.3% beneficial ownership of Class A ordinary shares in Agriculture & Natural Solutions Acquisition Corporation.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting a 4.3% beneficial ownership of Class A ordinary shares in Agriculture & Natural Solutions Acquisition Corporation.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 4.5% of Activate Energy Acquisition's Class A ordinary shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 4.5% of Activate Energy Acquisition's Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 3.0% of Abpro Holdings Inc.'s common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 3.0% of Abpro Holdings Inc.'s common stock.

Several entities associated with Millennium Management have updated their beneficial ownership filings for Metals Acquisition Corp. II, reporting significant holdings.

Paine Schwartz Food Chain Fund V GP, Ltd. reports beneficial ownership of over 60% of Suja Life, Inc.'s Class A common stock, signaling substantial investor confidence.

Several Hellman & Friedman affiliated entities have amended their Schedule 13G filing to report an aggregate beneficial ownership of 16.0% of Medline Inc.'s Class A common stock as of June 30, 2026.

Millennium Management LLC and affiliated entities have filed a Schedule 13G, reporting a combined beneficial ownership of 5.7% of Ardelyx, Inc. common stock as of June 30, 2026.

MIH Fintech Investments B.V., Naspers Limited, and Prosus N.V. have filed to report they no longer beneficially own any shares of Remitly Global, Inc. common stock.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 7,871,945 shares, representing 7.49% of the common stock of Two Harbors Investment Corp.

Glazer Capital, LLC and Paul J. Glazer have filed a Schedule 13G, reporting beneficial ownership of Forte Biosciences, Inc. common stock has fallen below the 5% threshold.